Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 260

1.

Health-related quality of life in oncology drug reimbursement submissions in Canada: A review of submissions to the pan-Canadian Oncology Drug Review.

Raymakers AJN, Regier DA, Peacock SJ.

Cancer. 2019 Sep 23. doi: 10.1002/cncr.32455. [Epub ahead of print]

PMID:
31544234
2.

Elevated urine oxalate and renal calculi in a classic galactosemia patient on soy-based formula.

Sabatino JA, Starin D, Tuchman S, Ferreira C, Regier DS.

JIMD Rep. 2019 Jun 21;49(1):7-10. doi: 10.1002/jmd2.12056. eCollection 2019 Sep.

3.

Demand for Precision Medicine: A Discrete-Choice Experiment and External Validation Study.

Regier DA, Veenstra DL, Basu A, Carlson JJ.

Pharmacoeconomics. 2019 Sep 6. doi: 10.1007/s40273-019-00834-0. [Epub ahead of print]

PMID:
31489595
4.

Whole-exome sequencing for diagnosis of Peters-plus syndrome after prenatal diagnosis of recurrent low PAPP-A and multiple fetal anomalies in two consecutive pregnancies.

Kamalapathy P, Fonda Allen JS, Macri CJ, Lawrence AK, Regier DS, Rubio EI.

J Neonatal Perinatal Med. 2019;12(3):333-338. doi: 10.3233/NPM-1854.

PMID:
31476172
5.

The Aspirations for a Paradigm Shift in DSM-5: An Oral History.

Zachar P, Regier DA, Kendler KS.

J Nerv Ment Dis. 2019 Sep;207(9):778-784. doi: 10.1097/NMD.0000000000001063.

PMID:
31464988
6.

GLB1-Related Disorders.

Regier DS, Tifft CJ.

In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019.
2013 Oct 17 [updated 2019 Aug 29].

7.

Clinical exome sequencing vs. usual care for hereditary colorectal cancer diagnosis: A pilot comparative effectiveness study.

Niu X, Amendola LM, Hart R, Bennette CS, Heagerty P, Horike-Pyne M, Trinidad SB, Rosenthal EA, Comstock B, Nefcy C, Hisama FM, Bennett RL, Grady WM, Gallego CJ, Tarczy-Hornoch P, Fullerton SM, Burke W, Regier DA, Dorschner MO, Shirts BH, Robertson PD, Nickerson DA, Patrick DL, Jarvik GP, Veenstra DL.

Contemp Clin Trials. 2019 Sep;84:105820. doi: 10.1016/j.cct.2019.105820. Epub 2019 Aug 7.

PMID:
31400517
8.

Clinical, biochemical and molecular characteristics of malonyl-CoA decarboxylase deficiency and long-term follow-up of nine patients.

Chapel-Crespo C, Gavrilov D, Sowa M, Myers J, Day-Salvatore DL, Lynn H, Regier D, Starin D, Steenari M, Schoonderwoerd K, Abdenur JE.

Mol Genet Metab. 2019 Jul 29. pii: S1096-7192(19)30274-4. doi: 10.1016/j.ymgme.2019.07.015. [Epub ahead of print] No abstract available.

9.

Validation of a Cyclic Algorithm to Proxy Number of Lines of Systemic Cancer Therapy Using Administrative Data.

Weymann D, Costa S, Regier DA.

JCO Clin Cancer Inform. 2019 Aug;3:1-10. doi: 10.1200/CCI.19.00022.

10.

Public perspectives on disinvestments in drug funding: results from a Canadian deliberative public engagement event on cancer drugs.

Costa S, Bentley C, Regier DA, McTaggart-Cowan H, Mitton C, Burgess MM, Peacock SJ.

BMC Public Health. 2019 Jul 22;19(1):977. doi: 10.1186/s12889-019-7303-2.

11.

Allocating healthcare resources to genomic testing in Canada: latest evidence and current challenges.

Weymann D, Dragojlovic N, Pollard S, Regier DA.

J Community Genet. 2019 Jul 5. doi: 10.1007/s12687-019-00428-5. [Epub ahead of print]

PMID:
31273679
12.

The EORTC QLU-C10D: The Canadian Valuation Study and Algorithm to Derive Cancer-Specific Utilities From the EORTC QLQ-C30.

McTaggart-Cowan H, King MT, Norman R, Costa DSJ, Pickard AS, Regier DA, Viney R, Peacock SJ.

MDM Policy Pract. 2019 Apr 13;4(1):2381468319842532. doi: 10.1177/2381468319842532. eCollection 2019 Jan-Jun.

13.

Whole-exome sequencing for diagnosis of Peters-plus syndrome after prenatal diagnosis of recurrent low PAPP-A and multiple fetal anomalies in two consecutive pregnancies.

Kamalapathy P, Fonda Allen JS, Macri CJ, Lawrence AK, Regier DS, Rubio EI.

J Neonatal Perinatal Med. 2019 May 7. doi: 10.3233/NPM-181854. [Epub ahead of print]

PMID:
31081795
14.

Real-world costing analysis for diffuse large B-cell lymphoma in British Columbia.

Costa S, Scott DW, Steidl C, Peacock SJ, Regier DA.

Curr Oncol. 2019 Apr;26(2):108-113. doi: 10.3747/co.26.4565. Epub 2019 Apr 1.

15.

The Feelings About genomiC Testing Results (FACToR) Questionnaire: Development and Preliminary Validation.

Li M, Bennette CS, Amendola LM, Ragan Hart M, Heagerty P, Comstock B, Tarczy-Hornoch P, Fullerton SM, Regier DA, Burke W, Trinidad SB, Jarvik GP, Veenstra DL, Patrick DL.

J Genet Couns. 2019 Apr;28(2):477-490. doi: 10.1007/s10897-018-0286-9. Epub 2018 Dec 14.

PMID:
30964586
16.

Balancing uncertainty with patient autonomy in precision medicine.

Pollard S, Sun S, Regier DA.

Nat Rev Genet. 2019 May;20(5):251-252. doi: 10.1038/s41576-019-0111-9. No abstract available.

PMID:
30872766
17.

Inborn Errors of Metabolism: From Preconception to Adulthood.

Kruszka P, Regier D.

Am Fam Physician. 2019 Jan 1;99(1):25-32.

PMID:
30600976
18.

Progress in achieving quantitative classification of psychopathology.

Krueger RF, Kotov R, Watson D, Forbes MK, Eaton NR, Ruggero CJ, Simms LJ, Widiger TA, Achenbach TM, Bach B, Bagby RM, Bornovalova MA, Carpenter WT, Chmielewski M, Cicero DC, Clark LA, Conway C, DeClercq B, DeYoung CG, Docherty AR, Drislane LE, First MB, Forbush KT, Hallquist M, Haltigan JD, Hopwood CJ, Ivanova MY, Jonas KG, Latzman RD, Markon KE, Miller JD, Morey LC, Mullins-Sweatt SN, Ormel J, Patalay P, Patrick CJ, Pincus AL, Regier DA, Reininghaus U, Rescorla LA, Samuel DB, Sellbom M, Shackman AJ, Skodol A, Slade T, South SC, Sunderland M, Tackett JL, Venables NC, Waldman ID, Waszczuk MA, Waugh MH, Wright AGC, Zald DH, Zimmermann J.

World Psychiatry. 2018 Oct;17(3):282-293. doi: 10.1002/wps.20566.

19.

Using "Big Data" in the Cost-Effectiveness Analysis of Next-Generation Sequencing Technologies: Challenges and Potential Solutions.

Wordsworth S, Doble B, Payne K, Buchanan J, Marshall DA, McCabe C, Regier DA.

Value Health. 2018 Sep;21(9):1048-1053. doi: 10.1016/j.jval.2018.06.016. Epub 2018 Aug 17. Erratum in: Value Health. 2019 Apr;22(4):502.

20.

Valuation of Health and Nonhealth Outcomes from Next-Generation Sequencing: Approaches, Challenges, and Solutions.

Regier DA, Weymann D, Buchanan J, Marshall DA, Wordsworth S.

Value Health. 2018 Sep;21(9):1043-1047. doi: 10.1016/j.jval.2018.06.010. Epub 2018 Aug 18. Review. Erratum in: Value Health. 2019 Apr;22(4):502.

21.

Methodological Issues in Assessing the Economic Value of Next-Generation Sequencing Tests: Many Challenges and Not Enough Solutions.

Phillips KA, Deverka PA, Marshall DA, Wordsworth S, Regier DA, Christensen KD, Buchanan J.

Value Health. 2018 Sep;21(9):1033-1042. doi: 10.1016/j.jval.2018.06.017. Epub 2018 Aug 8. Review. Erratum in: Value Health. 2019 Mar;22(3):383.

22.

The Feelings About genomiC Testing Results (FACToR) Questionnaire: Development and Preliminary Validation.

Li M, Bennette CS, Amendola LM, Ragan Hart M, Heagerty P, Comstock B, Tarczy-Hornoch P, Fullerton SM, Regier DA, Burke W, Trinidad SB, Jarvik GP, Veenstra DL, Patrick DL.

J Genet Couns. 2018 Sep 1. doi: 10.1007/s10897-018-0286-9. [Epub ahead of print]

PMID:
30173308
23.

Cancer drug expenditure in British Columbia and Saskatchewan: a trend analysis.

Pataky R, Tran DA, Coronado A, Alvi R, Boehm D, Regier DA, Peacock S.

CMAJ Open. 2018 Jul 27;6(3):E292-E299. doi: 10.9778/cmajo.20170161. Print 2018 Jul-Sep.

24.

Patient preferences for massively parallel sequencing genetic testing of colorectal cancer risk: a discrete choice experiment.

Weymann D, Veenstra DL, Jarvik GP, Regier DA.

Eur J Hum Genet. 2018 Sep;26(9):1257-1265. doi: 10.1038/s41431-018-0161-z. Epub 2018 May 25.

25.

Trade-offs, fairness, and funding for cancer drugs: key findings from a deliberative public engagement event in British Columbia, Canada.

Bentley C, Costa S, Burgess MM, Regier D, McTaggart-Cowan H, Peacock SJ.

BMC Health Serv Res. 2018 May 8;18(1):339. doi: 10.1186/s12913-018-3117-7.

26.

Uncertainty as a Driver of Mental Disorder Diagnostic Strategies.

Regier DA.

Psychiatry. 2017 Winter;80(4):309-314. doi: 10.1080/00332747.2017.1397453. No abstract available.

PMID:
29466108
27.

Medical genetics and genomic medicine in the United States. Part 2: Reproductive genetics, newborn screening, genetic counseling, training, and registries.

Regier DS, Ferreira CR, Hart S, Hadley DW, Muenke M.

Mol Genet Genomic Med. 2017 Nov;5(6):621-630. doi: 10.1002/mgg3.343.

28.

Pregnancy planning preferences among people and couples affected by human immunodeficiency virus: Piloting a discrete choice experiment.

Loutfy M, Kennedy VL, Sanandaji M, Barry F, Ongoiba F, Muchenje M, Tharao W, Regier DA.

Int J STD AIDS. 2018 Mar;29(4):382-391. doi: 10.1177/0956462417728188. Epub 2017 Sep 5.

PMID:
28872418
29.

Medical genetics and genomic medicine in the United States of America. Part 1: history, demographics, legislation, and burden of disease.

Ferreira CR, Regier DS, Hadley DW, Hart PS, Muenke M.

Mol Genet Genomic Med. 2017 Jul 16;5(4):307-316. doi: 10.1002/mgg3.318. eCollection 2017 Jul.

30.

Assessment of Individual Patient Preferences to Inform Clinical Practice.

Whitty JA, Fraenkel L, Saigal CS, Groothuis-Oudshoorn CGM, Regier DA, Marshall DA.

Patient. 2017 Aug;10(4):519-521. doi: 10.1007/s40271-017-0254-8. No abstract available.

PMID:
28597378
31.

Case 5: Acute Vomiting and Hallucinations in a 5-year-old Vegan Girl.

Magida Farrell L, Kalburgi S, McGarry-Hansen M, Regier DS.

Pediatr Rev. 2017 Jun;38(6):287. doi: 10.1542/pir.2016-0064. No abstract available.

PMID:
28572141
32.

The cost and cost trajectory of whole-genome analysis guiding treatment of patients with advanced cancers.

Weymann D, Laskin J, Roscoe R, Schrader KA, Chia S, Yip S, Cheung WY, Gelmon KA, Karsan A, Renouf DJ, Marra M, Regier DA.

Mol Genet Genomic Med. 2017 Mar 12;5(3):251-260. doi: 10.1002/mgg3.281. eCollection 2017 May.

33.

The Girls-Only HPV Vaccination Program in British Columbia, Canada: A Qualitative Study Exploring Expert Informants' Perspectives of Input From the Public.

McTaggart-Cowan H, Bentley C, Ogilvie G, Regier DA, Peacock SJ.

J Obstet Gynaecol Can. 2017 Sep;39(9):726-727. doi: 10.1016/j.jogc.2017.03.116. Epub 2017 May 13. No abstract available.

PMID:
28511920
34.

Exploring the Factors Considered by People Living with HIV and Their Partners during Preconception.

Kennedy VL, Collins M, Yudin MH, Serghides L, Walmsley S, Angel JB, Ongoiba F, Powis J, Smaill F, Tharao W, Rachlis A, Silverman M, Sandre R, Regier DA, Loutfy M.

J Int Assoc Provid AIDS Care. 2017 May/Jun;16(3):239-246. doi: 10.1177/2325957416682089. Epub 2016 Dec 19.

PMID:
28485707
35.

The Hierarchical Taxonomy of Psychopathology (HiTOP): A dimensional alternative to traditional nosologies.

Kotov R, Krueger RF, Watson D, Achenbach TM, Althoff RR, Bagby RM, Brown TA, Carpenter WT, Caspi A, Clark LA, Eaton NR, Forbes MK, Forbush KT, Goldberg D, Hasin D, Hyman SE, Ivanova MY, Lynam DR, Markon K, Miller JD, Moffitt TE, Morey LC, Mullins-Sweatt SN, Ormel J, Patrick CJ, Regier DA, Rescorla L, Ruggero CJ, Samuel DB, Sellbom M, Simms LJ, Skodol AE, Slade T, South SC, Tackett JL, Waldman ID, Waszczuk MA, Widiger TA, Wright AGC, Zimmerman M.

J Abnorm Psychol. 2017 May;126(4):454-477. doi: 10.1037/abn0000258. Epub 2017 Mar 23. Review.

PMID:
28333488
36.

Novel Biomarkers of Human GM1 Gangliosidosis Reflect the Clinical Efficacy of Gene Therapy in a Feline Model.

Gray-Edwards HL, Regier DS, Shirley JL, Randle AN, Salibi N, Thomas SE, Latour YL, Johnston J, Golas G, Maguire AS, Taylor AR, Sorjonen DC, McCurdy VJ, Christopherson PW, Bradbury AM, Beyers RJ, Johnson AK, Brunson BL, Cox NR, Baker HJ, Denney TS, Sena-Esteves M, Tifft CJ, Martin DR.

Mol Ther. 2017 Apr 5;25(4):892-903. doi: 10.1016/j.ymthe.2017.01.009. Epub 2017 Feb 22.

37.

Phenylalanine Hydroxylase Deficiency.

Regier DS, Greene CL.

In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019.
2000 Jan 10 [updated 2017 Jan 5].

38.

Diagnosis of LCHAD/TFP deficiency in an at risk newborn using umbilical cord blood acylcarnitine analysis.

Raval DB, Cusmano-Ozog KP, Ayyub O, Jenevein C, Kofman LH, Lanpher B, Hauser N, Regier DS.

Mol Genet Metab Rep. 2016 Dec 9;10:8-10. eCollection 2017 Mar.

39.

A time-and-motion approach to micro-costing of high-throughput genomic assays.

Costa S, Regier DA, Meissner B, Cromwell I, Ben-Neriah S, Chavez E, Hung S, Steidl C, Scott DW, Marra MA, Peacock SJ, Connors JM.

Curr Oncol. 2016 Oct;23(5):304-313. Epub 2016 Oct 25.

40.

Utility Estimates of Disease-Specific Health States in Prostate Cancer from Three Different Perspectives.

Gries KS, Regier DA, Ramsey SD, Patrick DL.

Appl Health Econ Health Policy. 2017 Jun;15(3):375-384. doi: 10.1007/s40258-016-0282-x.

PMID:
27704390
41.

Genetics: The Future Is Now with Interprofessional Collaboration.

Regier DS, Hart TC.

Dent Clin North Am. 2016 Oct;60(4):943-9. doi: 10.1016/j.cden.2016.03.005. Review.

PMID:
27671963
42.
43.

Diagnostic Categories: Provisional, Not Otherwise Classified, or Place-holder?

Carpenter WT, Regier D.

Schizophr Bull. 2016 Nov;42(6):1305-1306. Epub 2016 Aug 27. No abstract available.

44.

The GM1 and GM2 Gangliosidoses: Natural History and Progress toward Therapy.

Regier DS, Proia RL, D'Azzo A, Tifft CJ.

Pediatr Endocrinol Rev. 2016 Jun;13 Suppl 1:663-73. Review.

PMID:
27491214
45.

Cost-Effectiveness Analysis of Using Loss of Heterozygosity to Manage Premalignant Oral Dysplasia in British Columbia, Canada.

Cromwell I, Regier DA, Peacock SJ, Poh CF.

Oncologist. 2016 Sep;21(9):1099-106. doi: 10.1634/theoncologist.2015-0433. Epub 2016 Jul 11.

46.

Role of elosulfase alfa in mucopolysaccharidosis IVA.

Regier DS, Tanpaiboon P.

Appl Clin Genet. 2016 Jun 14;9:67-74. doi: 10.2147/TACG.S69080. eCollection 2016. Review.

47.

Economic impact of genomic diagnostics for intermediate-risk acute myeloid leukaemia.

Cressman S, Karsan A, Hogge DE, McPherson E, Bolbocean C, Regier DA, Peacock SJ.

Br J Haematol. 2016 Aug;174(4):526-35. doi: 10.1111/bjh.14076. Epub 2016 Apr 21.

48.

Preferences for Prostate Cancer Outcomes: A Comparison of the Patient Perspective, the General Population Perspective, and a Population at Risk for Prostate Cancer.

Gries KS, Regier DA, Ramsey SD, Patrick DL.

Value Health. 2016 Mar-Apr;19(2):218-25. doi: 10.1016/j.jval.2015.11.012. Epub 2016 Jan 14.

49.

Mucopolysaccharidosis Type IVA.

Regier DS, Oetgen M, Tanpaiboon P.

In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019.
2013 Jul 11 [updated 2016 Mar 24].

50.

MRI/MRS as a surrogate marker for clinical progression in GM1 gangliosidosis.

Regier DS, Kwon HJ, Johnston J, Golas G, Yang S, Wiggs E, Latour Y, Thomas S, Portner C, Adams D, Vezina G, Baker EH, Tifft CJ.

Am J Med Genet A. 2016 Mar;170(3):634-44. doi: 10.1002/ajmg.a.37468. Epub 2015 Dec 8.

PMID:
26646981

Supplemental Content

Loading ...
Support Center